Results 71 to 80 of about 6,613 (271)

Tiny carriers, big impact: How Fusobacterium nucleatum extracellular vesicles drive oral diseases and beyond

Interdisciplinary Medicine, EarlyView.
This review explores how Fusobacterium nucleatum extracellular vesicles drive local oral diseases and distal pathologies via sophisticated cross‐compartment cross talk. It highlights the transformative potential of these “tiny carriers” as next‐generation molecular intermediaries for advanced health monitoring and innovative bio‐interventions by ...
Rongyang Ma, Jiahui Huang, Yitong Chen, Haoxuan Wang, Hang Zou, Wanghong Zhao, Zilong Deng   +6 more
wiley   +1 more source

Deep learning‐assisted design of nanozyme for immune regulation

Journal of Intelligent Medicine, EarlyView.
Overview of nanozyme‐based strategies for inflammatory bowel disease therapy, featuring metal‐based and non‐metallic nanozymes classified by structure, alongside multifunctional and engineered probiotic‐based nanozymes classified by function. Abstract Inflammatory bowel disease (IBD), with rising global incidence and disease burden, is a multifactorial
Ke Chen, Si Sun, Shaofang Zhang, Huanhuan Qiao   +3 more
wiley   +1 more source

Proton pump inhibitor vs histamine 2 receptor antagonists for prophylaxis of stress ulcer in critically ill patients

, 2022
Introduction: stress ulcer is one of the serious complications in critically ill patients admitted to intensive care unit and associated with increase in mortality rate among them, proton pump inhibitor and histamine 2 receptor antagonist have been ...
Jabbar, Ali Hassan, Shawket, Anas Saad, Kadhim, Ghusson Ibrahim   +2 more
core   +1 more source

Immunomodulators, associated or not with systemic antibiotics, to treat periodontitis: A 1‐year multicenter, placebo‐controlled, double‐blind, randomized clinical trial

Journal of Periodontology, EarlyView.
Abstract Background Immunomodulatory agents such as omega‐3 (ω‐3) and low‐dose aspirin (ASA) have been proposed as effective adjuncts in the treatment of periodontitis. However, they still lack long‐term studies and head‐to‐head evaluation with metronidazole (MTZ) and amoxicillin (AMX), the adjunct protocol with the strongest scientific evidence of ...
Nidia C. Castro dos Santos, Rafael N. de Brito Silva, Fernanda S. Colombo, Ingrid Oliveira‐Cardoso, Lina J. Súarez, Rodrigo Martins, Luciene C. de Figueiredo, Heitor Marques Honório, Ademir Melo Leite Filho, Flavia A. C. Furlaneto, Michel R. Messora, Monique Furukawa, José Roberto Cortelli, Emanuel Silva Rovai, Magda Feres   +14 more
wiley   +1 more source

Histamine in stress ulcer prophylaxis in rats. [PDF]

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2001
Gastrin and its analogues increase the gastric acid secretion, but also enhance mucosal defense mechanisms. On the other hand, increased formation of histamine leading to an increase in gastric acid secretion is accompanied with gastroprotection and acceleration of gastric ulcer healing.Of this study was to examine the effect of histamine on stress ...
Warzecha, Zygmunt, Dembiński, Artur, Brzozowski, Tomasz, Ceranowicz, Piotr, Dembiński, Marcin, Stachura, J., Konturek, Stanisław   +6 more
openaire   +1 more source

Deep Vein Thrombosis and Stress Ulcer Prophylaxis in the Intensive Care Unit

, 2011
Deep vein thrombosis (DVT) and stress gastric ulcers can be serious complications in patients admitted to the intensive care unit. This review discusses the risk factors associated with the development of DVT and stress-related mucosal disease (SRMD ...
Jason A. Hoffman, Corey M. Goodwin
core   +1 more source

Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients

, 2020
Background: Stress ulcer is a superficial and asymptomatic lesion and causes bleeding. As many as 50% of death cases are reported as the result of stress ulcer bleeding.
Alderman, Christopher Paul, Matulatan, Fendy, Wijaya, Dhani, Ardianto, Chrismawan, Suharjono, Suharjono, Padolo, Elfri, Sumarno, Sumarno   +6 more
core   +1 more source

Raising the bar: Utilizing quality improvement tools to increase compliance with clinical care guidelines in inflammatory bowel disease patients

JPGN Reports, EarlyView.
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri, Emi Suzuki, Laura Bauman, Brent Polk, Jeannie S. Huang   +4 more
wiley   +1 more source

The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients

Advanced Biomedical Research, 2014
Background: Ventilator associated pneumonia (VAP) are one of the most common nosocomial infections in intensive care unit (ICU). The ICU patients are at risk of stress ulcer and gastrointestinal bleeding for different reasons.
Farzin Khorvash, Saeed Abbasi, Mohsen Meidani, Fatemeh Dehdashti, Behrooz Ataei   +4 more
doaj   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan, Christian Wysocki, Bhaskar Gurram   +2 more
wiley   +1 more source